The Pharmaceutical CRM Outlook: Optimizing returns from operational and analytical CRM

A new strategic management report from Reuters Business Insight

The new Reuters Business Insight report: ‘The Pharmaceutical CRM Outlook: Optimizing returns from operational and analytical investment’ analyzes the current operational and analytical CRM practises and outlines in detail the future developments that will increase the return on investment (ROI) within sales, marketing and customer fulfillment activities.

Improve your sales force effectiveness, maximize product usage and drive up your ROI with the help of this latest report…

Top three reasons why this is a 'must have' report this month:

Secure the most profitable customers and capitalize on CRM's potential to increase your customer's propensity to purchase products or services at a lowered cost of transaction.

Reduce set-up time and costs of CRM experimentation by learning from the industry leaders' best practice such as Roche, AstraZeneca and Merck.

Utilize technology-based solutions to increase the ROI from physician detailing and assess the viability of newer technologies, such as voice recognition and iTV.

Order Today!

To order these reports contact peter.barfoot@bioportfolio.com or telephone +44 1300 321501 or +1 415 680 2472 and a representative will get back to you.

You can also order on line at: http://www.bioportfolio.com/cgi-bin/acatalog/search.html